Product Description
Product name: Ginsenoside Rh2
C A S: 78214-33-2
Content: 4-90% (HPLC)
Appearance: yellow powder, off-white powder, white powder
Solubility: soluble in methanol, ethanol, glycerol, propylene glycol, slightly soluble in water, insoluble in petroleum ether.
Source: Panax ginseng
Packaging: 1kg / bag, 25kg / drum or packed on demand.
Ginsenoside Rh2 is a substance obtained by hydrolysis of ginsenoside, the main active substance of ginseng, and has a strong inhibitory effect on cancer cell proliferation. The content of ginsenoside Rh2 in red ginseng is only 1 / 100,000. Due to the low content, only a small number of patients could afford high levels of Rh2 products in the past.
A large amount of scientific literature shows that ginsenoside Rh2 has strong anti-tumor effect, but has no toxic and side effects on normal cells, and has a synergistic effect when combined with other chemotherapy drugs. The antitumor mechanism of ginsenoside Rh2 is very extensive. It mainly plays an antitumor role by regulating the tumor cell proliferation cycle, inducing cell differentiation and apoptosis. Inducing differentiation of tumor cells into normal cells is conducive to controlling tumor development, and inducing apoptosis of tumor cells causes the cells to disintegrate to form apoptotic bodies without causing inflammatory reactions in surrounding tissues. Ginsenoside Rh2 can also play an antitumor role by regulating and enhancing the body’s immune function.
The latest scientific research results show that ginsenoside Rh2 can inhibit cancer cells such as melanoma, breast cancer, ovarian cancer, liver cancer, lung cancer, bone cancer, pancreatic cancer, colon cancer, and blood cancer.
In addition to its anti-tumor effects, ginsenoside Rh2 also has the effects of improving the body’s immunity, antibacterial, improving the lack of blood supply to the heart and brain, regulating the central nervous system, anti-fatigue, and delaying aging.